📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A screen of 350 combination therapies with ¹⁷⁷Lu-DOTATATE reveal distinct differences to EBRT and novel action of CDK4/6 inhibitors (2020)

First Author: ONeill Edward

Attributed to: Imaging DNA damage repair during radionuclide therapy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Type: Conference/Paper/Proceeding/Abstract

Volume: 61

Parent Publication: JOURNAL OF NUCLEAR MEDICINE

ISSN: 0161-5505